Madhav Seshadri • UCSF Profiles

Madhav Seshadri, MD

Title(s)	Assistant Professor, Medicine
School	School of Medicine
Phone	--
ORCID	0000-0001-5106-1979
vCard	Download vCard

Biography

Education and Training

New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY		2022	Chief Fellow, Hematology and Oncology
New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY		2022	Fellowship, Hematology and Oncology
New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY		2019	Residency, Internal Medicine
Emory University School of Medicine, Atlanta, GA	MD	2016
Johns Hopkins University, Baltimore, MD	BA	2009	Neuroscience

Awards and Honors

American Society of Hematology	2021		Abstract Achievement Award
American Society of Hematology	2021 -	2022	Research Training Award for Fellows
Emory University School of Medicine	2015 -	2016	Ann Hoyt Jolley Merit Scholarship

Overview

I take care of people with lymphoma and chronic lymphocytic leukemia. I believe in taking an individualized approach to each patient's care. By understanding their values and priorities, together we will arrive at the best treatment plan.

I graduated with honors from Emory University School of Medicine in Atlanta. I completed residency in Internal Medicine and fellowship in Hematology and Oncology at New York Presbyterian Hospital/Weill Cornell Medical Center in New York, where I also served as Chief Fellow. At UCSF I am fortunate to practice at a leading medical center which is at the forefront of cancer care.

Technologies for the diagnosis and treatment of lymphoma and CLL are rapidly evolving, and I will use the latest advancements in providing care for patients. We are also fortunate to have a strong team of specialty consultants, nurse practitioners, nurses, medical technicians, pharmacists, and administrative staff. It would be a privilege to care for you or your family member.

Interests

Lymphoma, Chronic lymphocytic leukemia, Cellular therapy (including CAR-T), Immunotherapy, Clinical research

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Premortem Skin Biopsy Assessing Microthrombi, Interferon Type I Antiviral and Regulatory Proteins, and Complement Deposition Correlates with Coronavirus Disease 2019 Clinical Stage. Am J Pathol. 2022 09; 192(9):1282-1294. Laurence J, Nuovo G, Racine-Brzostek SE, Seshadri M, Elhadad S, Crowson AN, Mulvey JJ, Harp J, Ahamed J, Magro C. PMID: 35640675; PMCID: PMC9144849.

View in: PubMed Mentions: 9 Fields:
Pat Pathology
Translation:Humans
Ofatumumab for Post-Transplant Lymphoproliferative Disorder. Hematol Oncol Stem Cell Ther. 2022 Mar 01; 15(1):68-73. Seshadri M, Crane GM, Gergis U. PMID: 32413419.

View in: PubMed Mentions: 2 Fields:
Hem Hematology Neo Neoplasms
Translation:Humans Cells
Targeting MALT1 for the treatment of diffuse large B-cell lymphoma. Leuk Lymphoma. 2022 04; 63(4):789-798. Seshadri MR, Melnick AM. PMID: 34783281.

View in: PubMed Mentions: 5 Fields:
Hem Hematology Neo Neoplasms
Translation:Humans
Clinical outcomes in eight patients with immune thrombocytopenia each treated with the three approved thrombopoietin receptor agonists. Am J Hematol. 2021 10 01; 96(10):E373-E376. Lee EJ, Seshadri M, Bussel JB. PMID: 34152624.

View in: PubMed Mentions: 2 Fields:
Hem Hematology
Translation:Humans
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. Clin Immunol. 2020 10; 219:108555. Laurence J, Mulvey JJ, Seshadri M, Racanelli A, Harp J, Schenck EJ, Zappetti D, Horn EM, Magro CM. PMID: 32771488; PMCID: PMC7410014.

View in: PubMed Mentions: 61 Fields:
All Allergy and Immunology
Translation:Humans Cells PHPublic Health
Microenvironmental regulation of hematopoietic stem cells and its implications in leukemogenesis. Curr Opin Hematol. 2016 07; 23(4):339-45. Seshadri M, Qu CK. PMID: 27071022; PMCID: PMC5086033.

View in: PubMed Mentions: 7 Fields:
Hem Hematology
Translation:Humans Animals Cells
Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study. Int J Hyperthermia. 2016 08; 32(5):543-57. Attaluri A, Seshadri M, Mirpour S, Wabler M, Marinho T, Furqan M, Zhou H, De Paoli S, Gruettner C, Gilson W, DeWeese T, Garcia M, Ivkov R, Liapi E. PMID: 27151045; PMCID: PMC4936948.

View in: PubMed Mentions: 14 Fields:
Neo Neoplasms The Therapeutics
Translation:Humans Animals Cells
Snapin mediates incretin action and augments glucose-dependent insulin secretion. Cell Metab. 2011 Mar 02; 13(3):308-19. Song WJ, Seshadri M, Ashraf U, Mdluli T, Mondal P, Keil M, Azevedo M, Kirschner LS, Stratakis CA, Hussain MA. PMID: 21356520; PMCID: PMC3053597.

View in: PubMed Mentions: 54 Fields:
Cel Cell Biology Met Metabolism
Translation:Humans Animals Cells